Daily wine now sits in a gray zone between wellness trend and medical red flag. Health experts say the key variable is dose, not the drink’s romantic image. Ethanol, the active compound in wine, is classified as a Group 1 carcinogen, meaning any regular exposure can raise the probability of breast, colon and head and neck cancers, even when intake stays within so‑called moderate ranges.

The long‑touted heart benefits come with heavy caveats. Some studies link light wine intake to slightly lower rates of ischemic heart disease, likely via effects on high‑density lipoprotein and endothelial function, but cardiologists warn that the marginal effect is small and disappears as intake climbs. Once drinking becomes daily and routine, blood pressure, triglycerides and arrhythmia risk tend to move in the opposite direction.

Behind the scenes, the liver’s detoxification pathways and baseline metabolic rate work overtime to clear acetaldehyde, a toxic breakdown product that can damage DNA and promote fatty liver disease. Sleep quality often erodes, and dependence risk rises when alcohol becomes an automatic nightly coping tool. Most guidelines now advise keeping alcohol to low, non‑daily amounts and treating wine as an occasional choice, not a health strategy.

The glass on the table may look unchanged, but the balance between ritual and risk shifts with every refill.